IL95250A - 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments - Google Patents

1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments

Info

Publication number
IL95250A
IL95250A IL9525090A IL9525090A IL95250A IL 95250 A IL95250 A IL 95250A IL 9525090 A IL9525090 A IL 9525090A IL 9525090 A IL9525090 A IL 9525090A IL 95250 A IL95250 A IL 95250A
Authority
IL
Israel
Prior art keywords
hydrogen
compound
loweralkyl
pyrrolidinone
pyridinylamino
Prior art date
Application number
IL9525090A
Other languages
English (en)
Other versions
IL95250A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL95250A0 publication Critical patent/IL95250A0/xx
Publication of IL95250A publication Critical patent/IL95250A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
IL9525090A 1989-08-02 1990-07-31 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments IL95250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,413 US4994472A (en) 1989-08-02 1989-08-02 1-(pyridinylamino)-2-pyrrolidinones as pain relievers

Publications (2)

Publication Number Publication Date
IL95250A0 IL95250A0 (en) 1991-06-10
IL95250A true IL95250A (en) 1994-01-25

Family

ID=23534027

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9525090A IL95250A (en) 1989-08-02 1990-07-31 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments

Country Status (17)

Country Link
US (1) US4994472A (fr)
EP (1) EP0413191B1 (fr)
JP (1) JPH0674264B2 (fr)
KR (1) KR0164437B1 (fr)
AT (1) ATE109142T1 (fr)
AU (1) AU635051B2 (fr)
CA (1) CA2022484C (fr)
DE (1) DE69011013T2 (fr)
DK (1) DK0413191T3 (fr)
ES (1) ES2059929T3 (fr)
FI (1) FI903818A7 (fr)
IE (1) IE65117B1 (fr)
IL (1) IL95250A (fr)
NO (1) NO903388L (fr)
NZ (1) NZ234724A (fr)
PT (1) PT94878B (fr)
ZA (1) ZA906049B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356908A (en) * 1989-04-21 1994-10-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
IL96755A0 (en) * 1989-12-27 1991-09-16 Monsanto Co Substituted pyridine compounds
AUPM656594A0 (en) * 1994-06-30 1994-07-21 Orbital Engine Company (Australia) Proprietary Limited A method and apparatus relating to control of the operation of an internal combustion engine
JP4109718B2 (ja) * 1996-04-12 2008-07-02 アベンティス・ファーマスーティカルズ・インコーポレイテッド アセチルコリンエステラーゼ阻害剤および鎮痛剤としてのイサチン誘導体
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
CA2490494A1 (fr) * 2002-07-02 2004-01-15 Blanchette Rockefeller Neurosciences Institute Activation de la pkc utilisee pour renforcer la secretion de la sapp.alpha. et pour ameliorer la cognition au moyen de composes du type bryostatine
TW201206425A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
GB0412019D0 (en) * 2004-05-28 2004-06-30 Novartis Ag Organic compounds
US20070054890A1 (en) 2005-07-29 2007-03-08 Alkon Daniel L Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
EP3332797A3 (fr) 2007-02-09 2018-08-01 Blanchette Rockefeller Neurosciences Institute Effets thérapeutiques des bryostatines, bryologues et autres substances apparentées sur les troubles de la mémoire et les lésions cérébrales suite à un traumatisme crânien

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670184A1 (de) * 1967-01-20 1971-01-21 Boehringer Sohn Ingelheim Verfahren zur Herstellung heterocyclisch substituierter Hydrazino-imidazoline-(2)
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4324884A (en) * 1980-09-25 1982-04-13 General Electric Company Organic amine catalyzed method for making polyetherimide
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
JPH0699307B2 (ja) * 1987-08-20 1994-12-07 キッセイ薬品工業株式会社 抗痴呆剤
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines

Also Published As

Publication number Publication date
CA2022484A1 (fr) 1991-02-03
NO903388D0 (no) 1990-08-01
KR910004597A (ko) 1991-03-29
DE69011013T2 (de) 1994-12-22
PT94878A (pt) 1991-04-18
IL95250A0 (en) 1991-06-10
DK0413191T3 (da) 1994-10-24
JPH0368572A (ja) 1991-03-25
NZ234724A (en) 1992-01-29
ES2059929T3 (es) 1994-11-16
CA2022484C (fr) 2000-10-17
KR0164437B1 (ko) 1999-01-15
IE65117B1 (en) 1995-10-04
EP0413191A1 (fr) 1991-02-20
ATE109142T1 (de) 1994-08-15
PT94878B (pt) 1997-08-29
FI903818A7 (fi) 1991-02-03
DE69011013D1 (de) 1994-09-01
IE902786A1 (en) 1991-02-27
ZA906049B (en) 1991-04-24
EP0413191B1 (fr) 1994-07-27
JPH0674264B2 (ja) 1994-09-21
AU6000290A (en) 1991-02-07
AU635051B2 (en) 1993-03-11
FI903818A0 (fi) 1990-07-31
NO903388L (no) 1991-02-04
US4994472A (en) 1991-02-19

Similar Documents

Publication Publication Date Title
CN108349981B (zh) 新型的吡唑并[3，4－d]嘧啶化合物或其盐
FI91401B (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
US5006537A (en) 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
EP0892796B1 (fr) Derives d'isatine utilises comme inhibiteurs d'acetylcholinesterase et comme analgesiques
IL95250A (en) 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments
EP0415103B1 (fr) 2,3-Dihydro-1-(pyridinylamino)-indoles, procédé pour leur préparation et leur utilisation comme médicaments
KR100191386B1 (ko) 3-(1,2-벤즈이속사졸-3-일)-4-피리딘아민 및 유도체,이를 함유하는 약제학적 조성물 및 이의 제조방법
US5179099A (en) 2,3-dihydro-1-(pyridinylamino)-indoles
US5296488A (en) Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
EP0299345A2 (fr) Dihydro-1,4-oxazino(2,3-c)quinoléines, procédé et composés intermédiaires pour leur préparation et leur utilisation comme médicaments
US5216017A (en) Pyrrolo[2,3-b]indole-ketones and analogs
US5686626A (en) 1,3-dihydro-1-amino-2H-indol-2-ones
EP0456196A1 (fr) Pyrrolo(2,3-b)indole-cétones et analogues, un procédé pour leur préparation et leur utilisation comme médicaments
AU716997C (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
JPWO2002018344A1 (ja) 新規なエステル又はアミド誘導体

Legal Events

Date Code Title Description
FF Patent granted
HC Change of name of proprietor(s)
RH Patent void
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
KB Patent renewed